Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein α Variant with Balanced Safety and Effectiveness, from a Targeted Epitope Mammalian Cell-Displayed Antibody Library
Zhihong Wang(Hubei Provincial Center for Disease Control and Prevention), Longlong Luo(Unknown), Naijing Hu(Peking University), Liuzhong Zhou(Central South University), Guojiang Chen(Beijing Institute of Education), Dingmu Zhang(Central South University), Bing Shen(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Jing Wang(Naval Medical Research Command), Haitao Wang(Wuhan University), Caiping Ren(Central South University), Chunxia Qiao, Jiannan Feng(Academy of Military Medical Sciences), Jiaguo Wu(Hunan Normal University), Xinying Li(Central South University), Hui Peng(Guangzhou Eighth People's Hospital)
Cited by 6
Related Papers
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|535
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
|Journal of Clinical Oncology|2014|261
Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis
|Journal of Zhejiang University SCIENCE B|2020|165